Literature DB >> 24067981

Characterization of Mus musculus papillomavirus 1 infection in situ reveals an unusual pattern of late gene expression and capsid protein localization.

Alessandra Handisurya1, Patricia M Day, Cynthia D Thompson, Christopher B Buck, Yuk-Ying S Pang, Douglas R Lowy, John T Schiller.   

Abstract

Full-length genomic DNA of the recently identified laboratory mouse papillomavirus 1 (MusPV1) was synthesized in vitro and was used to establish and characterize a mouse model of papillomavirus pathobiology. MusPV1 DNA, whether naked or encapsidated by MusPV1 or human papillomavirus 16 (HPV 16) capsids, efficiently induced the outgrowth of papillomas as early as 3 weeks after application to abraded skin on the muzzles and tails of athymic NCr nude mice. High concentrations of virions were extracted from homogenized papillomatous tissues and were serially passaged for >10 generations. Neutralization by L1 antisera confirmed that infectious transmission was capsid mediated. Unexpectedly, the skin of the murine back was much less susceptible to virion-induced papillomas than the muzzle or tail. Although reporter pseudovirions readily transduced the skin of the back, infection with native MusPV1 resulted in less viral genome amplification and gene expression on the back, including reduced expression of the L1 protein and very low expression of the L2 protein, results that imply skin region-specific control of postentry aspects of the viral life cycle. Unexpectedly, L1 protein on the back was predominantly cytoplasmic, while on the tail the abundant L1 was cytoplasmic in the lower epithelial layers and nuclear in the upper layers. Nuclear localization of L1 occurred only in cells that coexpressed the minor capsid protein, L2. The pattern of L1 protein staining in the infected epithelium suggests that L1 expression occurs earlier in the MusPV1 life cycle than in the life cycle of high-risk HPV and that virion assembly is regulated by a previously undescribed mechanism.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24067981      PMCID: PMC3838223          DOI: 10.1128/JVI.02162-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  43 in total

1.  Assembly and translocation of papillomavirus capsid proteins.

Authors:  Luise Florin; Cornelia Sapp; Rolf E Streeck; Martin Sapp
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

2.  Systematic identification of cell cycle-dependent yeast nucleocytoplasmic shuttling proteins by prediction of composite motifs.

Authors:  Shunichi Kosugi; Masako Hasebe; Masaru Tomita; Hiroshi Yanagawa
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-11       Impact factor: 11.205

3.  The initial steps leading to papillomavirus infection occur on the basement membrane prior to cell surface binding.

Authors:  Rhonda C Kines; Cynthia D Thompson; Douglas R Lowy; John T Schiller; Patricia M Day
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-17       Impact factor: 11.205

4.  Reactivity of human sera in a sensitive, high-throughput pseudovirus-based papillomavirus neutralization assay for HPV16 and HPV18.

Authors:  Diana V Pastrana; Christopher B Buck; Yuk-Ying S Pang; Cynthia D Thompson; Philip E Castle; Peter C FitzGerald; Susanne Krüger Kjaer; Douglas R Lowy; John T Schiller
Journal:  Virology       Date:  2004-04-10       Impact factor: 3.616

5.  A novel rodent papillomavirus isolated from anogenital lesions in its natural host.

Authors:  Julia Nafz; Kai Schäfer; Su Feng Chen; Ignacio G Bravo; Myriam Ibberson; Ingo Nindl; Eggert Stockfleth; Frank Rösl
Journal:  Virology       Date:  2008-01-29       Impact factor: 3.616

6.  Murine skin and vaginal mucosa are similarly susceptible to infection by pseudovirions of different papillomavirus classifications and species.

Authors:  Alessandra Handisurya; Patricia M Day; Cynthia D Thompson; Christopher B Buck; Kihyuck Kwak; Richard B S Roden; Douglas R Lowy; John T Schiller
Journal:  Virology       Date:  2012-09-15       Impact factor: 3.616

7.  Papillomas and carcinomas in transgenic rabbits carrying EJ-ras DNA and cottontail rabbit papillomavirus DNA.

Authors:  X Peng; R O Olson; C B Christian; C M Lang; J W Kreider
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

8.  Efficient intracellular assembly of papillomaviral vectors.

Authors:  Christopher B Buck; Diana V Pastrana; Douglas R Lowy; John T Schiller
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

9.  Synthesis of viral DNA and late capsid protein L1 in parabasal spinous cell layers of naturally occurring benign warts infected with human papillomavirus type 1.

Authors:  K Egawa; A Iftner; J Doorbar; Y Honda; T Iftner
Journal:  Virology       Date:  2000-03-15       Impact factor: 3.616

10.  Isolation of three novel rat and mouse papillomaviruses and their genomic characterization.

Authors:  Eric Schulz; Marc Gottschling; Rainer G Ulrich; Dania Richter; Eggert Stockfleth; Ingo Nindl
Journal:  PLoS One       Date:  2012-10-15       Impact factor: 3.240

View more
  35 in total

1.  Absence of γ-Chain in Keratinocytes Alters Chemokine Secretion, Resulting in Reduced Immune Cell Recruitment.

Authors:  Karolin Nowak; Daniela Linzner; Adrian J Thrasher; Paul F Lambert; Wei-Li Di; Siobhan O Burns
Journal:  J Invest Dermatol       Date:  2017-06-17       Impact factor: 8.551

2.  A clinicopathological study of episomal papillomavirus infection of the human placenta and pregnancy complications.

Authors:  Tania L Slatter; Natalie Gly Hung; William M Clow; Janice A Royds; Celia J Devenish; Noelyn A Hung
Journal:  Mod Pathol       Date:  2015-08-21       Impact factor: 7.842

3.  Mouse papillomavirus infections spread to cutaneous sites with progression to malignancy.

Authors:  Nancy M Cladel; Lynn R Budgeon; Timothy K Cooper; Karla K Balogh; Neil D Christensen; Roland Myers; Vladimir Majerciak; Deanna Gotte; Zhi-Ming Zheng; Jiafen Hu
Journal:  J Gen Virol       Date:  2017-10       Impact factor: 3.891

Review 4.  Papillomavirus assembly: An overview and perspectives.

Authors:  Carla Cerqueira; John T Schiller
Journal:  Virus Res       Date:  2016-11-10       Impact factor: 3.303

5.  Development of an in vivo infection model to study Mouse papillomavirus-1 (MmuPV1).

Authors:  Aayushi Uberoi; Satoshi Yoshida; Paul F Lambert
Journal:  J Virol Methods       Date:  2017-12-15       Impact factor: 2.014

6.  Human Papillomavirus 16 Capsids Mediate Nuclear Entry during Infection.

Authors:  Patricia M Day; Andrea S Weisberg; Cynthia D Thompson; Michelle M Hughes; Yuk Ying Pang; Douglas R Lowy; John T Schiller
Journal:  J Virol       Date:  2019-07-17       Impact factor: 5.103

7.  The HPV16 and MusPV1 papillomaviruses initially interact with distinct host components on the basement membrane.

Authors:  Patricia M Day; Cynthia D Thompson; Douglas R Lowy; John T Schiller
Journal:  Virology       Date:  2015-03-12       Impact factor: 3.616

8.  Insights into the Role of Innate Immunity in Cervicovaginal Papillomavirus Infection from Studies Using Gene-Deficient Mice.

Authors:  Carolina Scagnolari; Fabiana Cannella; Alessandra Pierangeli; Rebecca Mellinger Pilgrim; Guido Antonelli; Dayana Rowley; Margaret Wong; Simon Best; Deyin Xing; Richard B S Roden; Raphael Viscidi
Journal:  J Virol       Date:  2020-06-01       Impact factor: 5.103

9.  The human papillomavirus 16 E5 gene potentiates MmuPV1-Dependent pathogenesis.

Authors:  Alexandra D Torres; Megan E Spurgeon; Andrea Bilger; Simon Blaine-Sauer; Aayushi Uberoi; Darya Buehler; Stephanie M McGregor; Ella Ward-Shaw; Paul F Lambert
Journal:  Virology       Date:  2019-12-05       Impact factor: 3.616

Review 10.  Mus musculus Papillomavirus 1: a New Frontier in Animal Models of Papillomavirus Pathogenesis.

Authors:  Megan E Spurgeon; Paul F Lambert
Journal:  J Virol       Date:  2020-04-16       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.